Can Your Laboratory Meet The Demands Of Today's Bioprocessing Landscape?

By Richard Mirro, Business Manager, Bioprocess, Eppendorf

As the industry shifts its focus from blockbuster drugs to niche drugs for targeted patient populations, the market for biologics is evolving. Batch sizes are decreasing and the global footprint is expanding, leading to a greater need for efficiency in development and manufacturing, in order to make drugs more quickly and at a lower cost. Relying on slow R&D processes in this fast-changing environment will prevent you from not only increasing your speed to market but also standing out among your competitors. By adapting to today’s demands using smart bioprocessing, you can help drive efficiency in your laboratory and contribute to the economical and reliable production of next-generation molecules.